Aeovian Pharmaceuticals announced it raised $50.4 Million in an initial filing from an offering of $50.4 Million

May 13, 2024•over 1 year ago

Amount Raised

$50.4 Million

BerkeleyBiopharmaBiotechnology

Company Information

Company

Aeovian Pharmaceuticals

Location

Berkeley, California, United States

About

Aeovian Pharmaceuticals is a clinical-stage biopharmaceutical company developing targeted and highly selective small molecules to restore cellular metabolic quality control, thereby addressing the dysregulated growth and hyperactive signaling found in certain rare genetic and age-related diseases.

Related People

1 contact

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Aeovian Pharmaceuticals announced it raised $50.4 Million in an initial filing from an offering of $50.4 Million

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Funding Insights

Company Information